| Identification | Back Directory | [Name]
6H-Imidazo[4,5-f]quinoline-6-carboxylic acid, 3-[(1R,3R)-3-carboxycyclohexyl]-2-[(R)-(5-fluoro-2-methoxyphenyl)hydroxymethyl]-3,7,8,9-tetrahydro-7-methyl-, 6-methyl ester, (7S)- | [CAS]
2304372-79-8 | [Synonyms]
6H-Imidazo[4,5-f]quinoline-6-carboxylic acid, 3-[(1R,3R)-3-carboxycyclohexyl]-2-[(R)-(5-fluoro-2-methoxyphenyl)hydroxymethyl]-3,7,8,9-tetrahydro-7-methyl-, 6-methyl ester, (7S)- | [Molecular Formula]
C28H32FN3O6 | [MOL File]
2304372-79-8.mol | [Molecular Weight]
525.57 |
| Hazard Information | Back Directory | [Description]
Pocenbrodib is a histone acetyltransferase p300 inhibitor and CREB-binding protein (CBP) inhibitor with potential as an antineoplastic agent. | [Uses]
Pocenbrodib (compound II) is a CBP/p300 family of bromodomain inhibitor. Pocenbrodib has the potential for cancer research[1]. | [References]
[1] George Luke. Inhibiting cyclic amp-responsive element-binding protein (creb). WO2020190780A1. |
|
|